HIV nutrition boost: Cassava-Sesame granules show promise
NCT ID NCT07620197
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether daily cassava root and sesame seed granules, along with nutrition education, could improve the nutritional health of adults with HIV. Sixty-four participants took part, receiving either the granules plus education or education alone for 16 weeks. The goal was to see if this simple food supplement could help address malnutrition common in people living with HIV.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- cassava root and sesame seed granules
- What this could lead to
- If it works, this could point toward a simple, affordable way to improve nutrition and health in people living with HIV.
- What could go wrong
- This is a small, completed study with only 64 participants. The results may not apply to everyone, and the granules alone are unlikely to replace standard HIV care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
64 people
The number who actually took part.
- Started
-
Apr 2024
- Finished
-
Dec 2024
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
19 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * HIV-seropositive adults aged 19 - 50 years * Enrolled at the two study sites * willing to consent to participate in the study * Body Mass Index (BMI) of \> 16 kg/m2 - \< 18.5 kg/m2 * Hemoglobin levels 8g/dL - 12g/dL for non-pregnant women * Hemoglobin levels 8g/dL - 13 g/dL for men Exclusion Criteria: * Severe acute malnutrition BMI of \< 16 kg/m2 * Hemoglobin levels of \< 8 g/dL * Chronic conditions * Pregnant mothers
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIV (human immunodeficiency virus) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Chulaimbo County Hospital
Kisumu, 40105, Kenya
-
Nyahera Sub County Hospital
Kisumu, 40105, Kenya
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a Once-Daily HIV pill with food match Twice-Daily dosing during TB treatment?
- Four weeks vs twelve weeks: can a shorter TB prevention course work?
- Can a phone app keep young people with HIV engaged in care?
- Massive Real-World database aims to map how chronic diseases interact
- Can IV nutrition at an outpatient clinic help malnourished surgery patients?
- How do HIV drugs behave when kidneys fail? study measures blood levels